Dear Editor,

This letter is in response to the article written by Davoodabady *et al*.\[[@ref1]\] Unconscious patients are prone to exposure keratopathy, especially due to loss of cornea reflex and lack of tear production, which are natural protective mechanisms for the eyes.\[[@ref2]\] Such patients cannot nictitate and close their eyelid due to reduction in consciousness level and receiving tranquilizers and anesthetic medicines. As a result, the risk of eye injuries such as dryness, abrasion, tear, and keratitis increases.\[[@ref3]\]

The authors presented their methodology; however, some inadequacies have been identified.

The authors reported to have applied some inclusion and exclusion criteria; however, if the study was initiated on the first day of patients\' admission, it would be difficult, if not impossible, to effectively uphold the inclusion and exclusion criteria in the study protocol.

The increase in the occurrence reported by the authors could have been caused by the interaction between normal saline and other treatments applied. It would have been more appropriate to have a third group who will receive only normal saline or upholding the two groups by giving one group normal saline and the other group ointment and artificial tears. Because one eye of all the patients was used as control, the authors should present their results in relation to the untreated eye. This would tell readers whether the new occurrence of keratopathy affected both eyes or just the treated eye.

It was not reported by the authors whether the artificial tear solution used was examined to rule out preservatives which may also irritate the eye. More details about the constituents of the artificial tear solution would be useful, especially when this study is to be replicated. A previous study has reported that artificial tear solution containing hydroxypropyl guar was more effective than normal saline where normal saline did not produce any significant changes.\[[@ref4]\]

The randomization of participants into study groups was defective because there was no assurance of homogeneity among study participants. Because some (14%) of the participants already had keratopathy even before the study, it is not clear how the authors performed randomization ensuring homogeneity between the control and intervention groups.
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